1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters by Title

Showing 1,267 results.

$Thumbnail for Safety and Preliminary Efficacy of Olverembatinib (HQP1351) Combined With Lisaftoclax (APG-2575) in Children and Adolescents With Relapsed/Refractory Philadelphia-Positive Acute Lymphoblastic Leukemia: Results of a Phase 1b Study$

ALL - 584

Safety and Preliminary Efficacy of Olverembatinib (HQP1351) Combined With Lisaftoclax (APG-2575) in Children and Adolescents With Relapsed/Refractory Philadelphia-Positive Acute Lymphoblastic Leukemia: Results of a Phase 1b Study

Jeffrey Rubnitz

Poster Presenter: Jeffrey Rubnitz

Thumbnail for Safety and Reliability of Isatuximab Subcutaneous On-Body Injector: Results Across the Phase 3 IRAKLIA, Phase 2 IZALCO and Phase 1b TCD15484 Trials

MM - 754

Safety and Reliability of Isatuximab Subcutaneous On-Body Injector: Results Across the Phase 3 IRAKLIA, Phase 2 IZALCO and Phase 1b TCD15484 Trials

Sloan Smith

Poster Presenter: Sloan Smith

SOHO 2026 Annual Meeting

Posters by Title

Safety and Preliminary Efficacy of Olverembatinib (HQP1351) Combined With Lisaftoclax (APG-2575) in Children and Adolescents With Relapsed/Refractory Philadelphia-Positive Acute Lymphoblastic Leukemia: Results of a Phase 1b Study

Safety and Reliability of Isatuximab Subcutaneous On-Body Injector: Results Across the Phase 3 IRAKLIA, Phase 2 IZALCO and Phase 1b TCD15484 Trials

Safety Profile of Elotuzumab-Based Regimens in Multiple Myeloma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Safety, Tolerability and Clinical Activity of Anito-cel in RRMM

Salvage Chemotherapy Intensity Does Not Impact Survival in Relapsed/Refractory Acute Myeloid Leukemia: A Single-Center Retrospective Analysis

Sarcopenia and Body Composition as Predictors of CAR-T Cell Therapy Outcomes in Hematologic Malignancies: A Systematic Review and Pooled Analysis

Second primary malignancies after CAR-T versus SCT in multiple myeloma

Second Primary Malignancies After Mantle Cell Lymphoma: A Population-Based SEER Analysis of Cancer-Specific and Long-Term Risk

Second Primary Malignancies in Cutaneous T-Cell Lymphoma: A Retrospective Population-Based Analysis